iP2P Mentorship Program for Teen HF Patients
- Conditions
- Heart Failure
- Interventions
- Behavioral: iPeer2Peer Program
- Registration Number
- NCT05709132
- Lead Sponsor
- The Hospital for Sick Children
- Brief Summary
The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A waitlist hybrid implementation-effectiveness type 3 pilot randomized controlled trial design will be employed across four sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-25 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 55
Not provided
- significant cognitive impairments as assessed by a qualified healthcare provider,
- a diagnosis of an active psychological disorder (e.g., Major Depressive Disorder, Generalized Anxiety Disorder) likely to influence assessment of health-related quality of life and/or interfere with their ability to manage their heart failure care regimen (a diagnosis of an active psychological disorder will be determined for mentees through medical chart review and self-reported by mentors), and
- participating in other peer support or self-management interventions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description iPeer2Peer Program iPeer2Peer Program -
- Primary Outcome Measures
Name Time Method Acceptability (Mentees) 15 weeks after baseline/immediately after the intervention Whether the innovation is agreeable, palatable or satisfactory
Feasibility (Mentees) Baseline to 12 weeks post-program completion The extent to which an innovation can be used or carried out successfully in a given setting
Feasibility (Mentors) Baseline to study completion, an average of 1 year The extent to which an innovation can be used or carried out successfully in a given setting
Appropriateness (Mentees) Baseline to 12 weeks post-program completion The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Level of engagement (Mentees) 15 weeks after baseline/immediately after the intervention Appropriateness (Mentors) Baseline to study completion, an average of 1 year The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Level of engagement (Mentors) Study completion, an average of 1 year Acceptability (Mentors) Study completion, an average of 1 year Whether the innovation is agreeable, palatable or satisfactory
Adoption (Mentees) Baseline to 12 weeks post-program completion The intention, initial decision or action to try or use an innovation
Adoption (Mentors) Baseline to study completion, an average of 1 year The intention, initial decision or action to try or use an innovation
- Secondary Outcome Measures
Name Time Method Resiliency (Mentees) Baseline to 12 weeks post-program completion Disease self-management skills (Mentees) Baseline to 12 weeks post-program completion Emotional distress (Mentees) Baseline to 12 weeks post-program completion Perceived social role satisfaction (Mentors) Baseline to study completion, an average of 1 year Self-efficacy (Mentors) Baseline to study completion, an average of 1 year Assessment of mentor quality (Mentees) 15 weeks after baseline/immediately after the intervention Physical and emotional symptoms (Mentors) Baseline to study completion, an average of 1 year Adherence (Mentees) Baseline to 12 weeks post-program completion Clinic attendance, completion of scheduled tests and procedures, and adolescent medication barriers scale
Perceived social support (Mentees) Baseline to 12 weeks post-program completion Quality of life (Mentees) Baseline to 12 weeks post-program completion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The Hospital for Sick Children
🇨🇦Toronto, Ontario, Canada
The Hospital for Sick Children🇨🇦Toronto, Ontario, CanadaSamantha J Anthony, PhDPrincipal Investigator